Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial.
Ross HJ, Kozono D, Wang XF, Urbanic JJ, Williams TM, Nelson GD, Carbone DP, Chung D, Robb R, Byun WY, Talabere T, DuFrane C, Bara I, Schulze K, Brockman M, Gao J, Vokes EE, Stinchcombe TE. Ross HJ, et al. Among authors: kozono d. JAMA Oncol. 2024 Sep 1;10(9):1212-1219. doi: 10.1001/jamaoncol.2024.1897. JAMA Oncol. 2024. PMID: 39052256 Clinical Trial.
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial.
Altorki N, Wang X, Damman B, Jones DR, Wigle D, Port J, Conti M, Ashrafi AS, Lieberman M, Landreneau R, Yasufuku K, Yang S, Mitchell JD, Keenan R, Bauer T, Miller D, Kozono D, Mentlick J, Vokes E, Stinchcombe TE. Altorki N, et al. Among authors: kozono d. JAMA Oncol. 2024 Sep 1;10(9):1179-1186. doi: 10.1001/jamaoncol.2024.2491. JAMA Oncol. 2024. PMID: 39088196 Clinical Trial.
The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.
Chang AEB, Piper-Vallillo AJ, Mak RH, Lanuti M, Muzikansky A, Rotow J, Jänne PA, Mino-Kenudson M, Swanson S, Wright CD, Kozono D, Marcoux P, Piotrowska Z, Sequist LV, Willers H. Chang AEB, et al. Among authors: kozono d. Oncologist. 2024 Jul 5;29(7):609-618. doi: 10.1093/oncolo/oyae107. Oncologist. 2024. PMID: 38761385 Free PMC article. Clinical Trial.
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy.
Atkins KM, Zhang SC, Kehayias C, Guthier C, He J, Gasho JO, Bakhtiar M, Silos KD, Kozono DE, Zei PC, Nohria A, Nikolova AP, Mak RH. Atkins KM, et al. Among authors: kozono de. JACC CardioOncol. 2024 Aug 20;6(4):544-556. doi: 10.1016/j.jaccao.2024.07.005. eCollection 2024 Aug. JACC CardioOncol. 2024. PMID: 39239344 Free PMC article.
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.
Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, Hariharan S, Hammad TA, Lindenfeld J, Murphy MJ, Moslehi JJ; Checkpoint Inhibitor Safety Working Group. Neilan TG, et al. Oncologist. 2018 Aug;23(8):874-878. doi: 10.1634/theoncologist.2018-0157. Epub 2018 May 25. Oncologist. 2018. PMID: 29802220 Free PMC article.
Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors.
Lee HY, Lee G, Ferguson D, Hsu SH, Hu YH, Huynh E, Sudhyadhom A, Williams CL, Cagney DN, Fitzgerald KJ, Kann BH, Kozono D, Leeman JE, Mak RH, Han Z. Lee HY, et al. Among authors: kozono d. Biomed Phys Eng Express. 2024 Jun 20;10(4). doi: 10.1088/2057-1976/ad567d. Biomed Phys Eng Express. 2024. PMID: 38861951
92 results